ES Pharma
ActiveSummary
ES Pharma has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €90,644 and a net result of €16,341. Equity is growing by about 3.3% per year across the filed financial years. Its solvency ranks better than 77% of 9,633 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
25-03
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
01-04
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
30-09
Financial
Back to profitnet €6,095
Net result €6,095 after one loss-making year.
21-02
NBB filing
Annual accounts filed
financial year 2023 · micro format
02-02
Gazette deed
Resignation: Sandrin Eric (manager)Appointment: Sandrin Eric (director) · Legal-form conversion · Amendment of the articles10 facts ▸
Gazette deed
Resignation: Sandrin Eric (manager)
Appointment: Sandrin Eric (director) · Legal-form conversion · Amendment of the articles10 facts ▸
- Legal-form conversion, “Société à Responsabilité Limitée” (deed in French)
- Amendment of the articles (2 times)
- Capital conversion, “compte de capitaux propres statutairement indisponibles” (deed in French)
- Reserve release, “supprimer le compte de capitaux propres statutairement indisponible et rendre les fonds disponibles pour distribution”, 22000.0 (deed in French)
- Purpose change
- Registered-office move, 7090 Braine-le-Comte, rue Maurice Brancart, 11
- Capital
- Director resignation, Sandrin Eric (manager)
- Director appointment, Sandrin Eric (director (not named in the articles))
- Power of attorney, Matthieu VAN MOLLE
2023
31-08
Financial
Weakest financial yearnet -€27,300
Net result drops to -€27,300, the lowest in the series; recovery starts the following year.
31-01
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-08
Financial
Liquidity more than doubledcurrent ratio 13.91
Current ratio from 6.64 to 13.91; short-term debt falls from €14,768 to €8,071.
31-08
Financial
Equity above €100,000equity €108,850 ▲15.6%
A profit in every financial year since 2020 builds equity to €108,850.
16-02
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
09-02
NBB filing
Annual accounts filed
financial year 2020 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.